254 results
Page 2 of 13
SUPPL
0brurb7idxwon90kf pw
26 Oct 23
Supplemental materials (foreign)
9:13pm
6-K
EX-99.1
0m8y9r3g
26 Oct 23
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
9:50am
SUPPL
om7ri376a44hzb7f36m
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
18xvrm2 t40h
25 Oct 23
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
5:31pm
6-K
EX-99.1
4aple6wcdy
24 Oct 23
Theratechnologies Announces Operational Update
8:24am
6-K
EX-99.1
dndyj486oy0hf
16 Oct 23
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
3:04pm
6-K
EX-99.1
vm7dw
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.1
b3lug3wej akgq
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
liaoe31k9aj 8b1s
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
no6rc4 b28i5
25 Sep 23
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
11:40am
6-K
EX-99.1
9bz8q 1kwtzya
31 Jul 23
Theratechnologies Completes 1-for-4 Reverse Stock Split
11:12am
6-K
EX-99.1
5jwdlvisg2a3xj
28 Jul 23
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
5:20pm
6-K
EX-99.1
ry9eytwzddh7yyjg8
20 Jul 23
Theratechnologies Announces 1-for-4 Reverse Stock Split
8:00am
6-K
EX-99.1
jwqth9q2eo1gm56o
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.2
y9hax3
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.1
hl8big 44tj1h17
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
6-K
EX-99.1
0969rqs8 m6tn4stmh
22 Jun 23
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
8:00am
6-K
EX-99.1
4195cz2ip5assdfau52
2 Jun 23
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
1:02pm
6-K
EX-99.1
t9l04xo5 j8ecp
9 May 23
Theratechnologies Reports on its Annual Meeting of Shareholders
2:48pm
6-K
EX-99.2
4jx3l8pmxsyyz9j
13 Apr 23
Notice of Annual Meeting of Shareholders
8:01am